About this medicine
- Approved name
- Somatropin
- International non-proprietary name (INN) or common name
- somatropin
- Associated names
- Genotropin
- Humatrope
- Maxomat
- Norditropin
- Saizen
- Zomacton
About this procedure
- Current status
- European Commission final decision
- Reference number
- EMEA/H/A-107/001287
- Type
- Article 107 procedures (prior to July 2012)
This type of procedure was triggered when a Member State varied, suspended or revoked the marketing authorisation for a medicine in its territory because of a safety issue. This procedure has been replaced by Article 107i.
Key dates and outcomes
- CHMP opinion date
- 15/12/2011
- EC decision date
- 27/02/2012